DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Ovide is a drug marketed by Taro Pharm Inds Ltd and is included in one NDA. There are two patents protecting this drug and one Paragraph IV challenge.
This drug has ten patent family members in seven countries.
The generic ingredient in OVIDE is malathion. There are three drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the malathion profile page.
A generic version of OVIDE was approved as malathion by SUVEN PHARMS on May 23rd, 2012.
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|Taro Pharm Inds Ltd||OVIDE||malathion||LOTION;TOPICAL||018613-001||Aug 2, 1982||DISCN||Yes||No||Start Trial||Start Trial||Y||Y||Start Trial|
|Taro Pharm Inds Ltd||OVIDE||malathion||LOTION;TOPICAL||018613-001||Aug 2, 1982||DISCN||Yes||No||Start Trial||Start Trial||Y||Start Trial|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>TE||>Type||>RLD||>RS||>Patent No.||>Patent Expiration||>Product||>Substance||>Delist Req.||>Exclusivity Expiration|